Earnings calendar/TCBIO
TEXAS CAPITAL BANCSHARES INC/TX (TCBIO)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter TEXAS CAPITAL BANCSHARES INC/TX has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
Filed
Jul 23, 2026
Filing date on record
EPS (diluted)
$1.77
Est. $1.88 · -5.9%
Revenue
$439.9M
Est. $333.4M · +32.0%
Net income
$84.9M
As filed
EPS YoY
+12.0%
vs quarter ended 2025-06-30
Revenue YoY
-10.9%
vs quarter ended 2025-06-30
Next report
Oct 21, 2026
Scheduled · est. EPS $1.95
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$7.63
2025-09-30 through 2026-06-30
TTM revenue
$1.96B
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
75%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-07-23 | $1.77 | $439.9M | +12.0% | -10.9% | $1.88 | -5.9% |
| 2026-03-31Q1 FY2026 | 2026-04-23 | $1.56 | $488.4M | +69.6% | +3.5% | $1.40 | +11.4% |
| 2025-12-31Q4 FY2025 | 2026-02-10 | $2.12 | $504.4M | +48.3% | +2.6% | $1.77 | +19.8% |
| 2025-09-30Q3 FY2025 | 2025-10-23 | $2.18 | $529.2M | +253.5% | +56.7% | $1.77 | +23.2% |
| 2025-06-30Q2 FY2025 | 2025-07-17 | $1.58 | $493.6M | +97.5% | +4.5% | $1.29 | +22.5% |
| 2025-03-31Q1 FY2025 | 2025-04-17 | $0.92 | $471.7M | +100.0% | +2.8% | $0.95 | -3.5% |
| 2024-12-31Q4 FY2024 | 2025-02-11 | $1.43 | $491.6M | +333.3% | +9.7% | — | — |
| 2024-09-30Q3 FY2024 | 2024-10-17 | $-1.42 | $337.8M | -220.3% | -28.5% | — | — |
| 2024-06-30Q2 FY2024 | 2024-07-18 | $0.80 | $472.5M | -39.8% | +5.5% | — | — |
| 2024-03-31Q1 FY2024 | 2024-04-18 | $0.46 | $458.7M | -34.3% | +8.5% | — | — |
| 2023-12-31Q4 FY2023 | 2024-02-13 | $0.33 | $448.2M | -92.2% | +11.9% | — | — |
| 2023-09-30Q3 FY2023 | 2023-10-19 | $1.18 | $472.6M | +59.5% | +36.0% | $1.01 | +16.8% |
| 2023-06-30Q2 FY2023 | 2023-07-20 | $1.33 | $447.9M | +125.4% | +66.8% | — | — |
| 2023-03-31Q1 FY2023 | 2023-04-20 | $0.70 | $422.6M | +1.4% | +84.7% | — | — |
| 2022-12-31Q4 FY2022 | 2023-02-09 | $4.23 | $400.4M | +255.5% | +59.3% | — | — |
| 2022-09-30Q3 FY2022 | 2022-10-20 | $0.74 | $347.4M | -2.6% | +45.4% | — | — |
| 2022-06-30Q2 FY2022 | 2022-07-21 | $0.59 | $268.6M | -55.0% | +10.9% | — | — |
| 2022-03-31Q1 FY2022 | 2022-04-21 | $0.69 | $228.8M | -48.9% | -10.1% | — | — |
| 2021-12-31Q4 FY2021 | 2022-02-09 | $1.19 | $251.3M | +4.4% | -10.9% | — | — |
| 2021-09-30Q3 FY2021 | 2021-10-21 | $0.76 | $239.0M | -29.6% | -18.1% | — | — |
| 2021-06-30Q2 FY2021 | 2021-07-22 | $1.31 | $242.2M | +279.5% | -19.9% | — | — |
| 2021-03-31Q1 FY2021 | 2021-04-22 | $1.35 | $254.5M | +455.3% | -15.6% | — | — |
| 2020-12-31Q4 FY2020 | 2021-02-09 | $1.14 | $282.2M | -19.7% | -20.0% | — | — |
| 2020-09-30Q3 FY2020 | 2020-10-22 | $1.08 | $291.8M | -36.5% | -20.5% | — | — |
| 2020-06-30Q2 FY2020 | 2020-07-24 | $-0.73 | $302.4M | -148.7% | -17.2% | — | — |
| 2020-03-31Q1 FY2020 | 2020-04-24 | $-0.38 | $301.4M | -123.7% | -13.9% | — | — |
| 2019-12-31Q4 FY2019 | 2020-02-12 | $1.42 | $352.6M | +2.9% | +5.4% | — | — |
| 2019-09-30Q3 FY2019 | 2019-10-17 | $1.70 | $367.2M | +3.0% | +13.7% | — | — |
| 2019-06-30Q2 FY2019 | 2019-07-18 | $1.50 | $365.2M | +8.7% | +21.8% | — | — |
| 2019-03-31Q1 FY2019 | 2019-04-18 | $1.60 | $350.2M | +15.9% | +29.7% | — | — |
| 2018-12-31Q4 FY2018 | 2019-02-14 | $1.38 | $334.4M | +64.3% | +27.8% | — | — |
| 2018-09-30Q3 FY2018 | 2018-10-18 | $1.65 | $323.1M | +47.3% | +27.8% | — | — |
| 2018-06-30Q2 FY2018 | 2018-07-19 | $1.38 | $299.8M | +42.3% | +33.7% | — | — |
| 2018-03-31Q1 FY2018 | 2018-04-19 | $1.38 | $270.0M | +72.5% | +35.5% | — | — |
| 2017-12-31Q4 FY2017 | 2018-02-14 | $0.84 | $261.7M | -12.5% | +26.1% | — | — |
| 2017-09-30Q3 FY2017 | 2017-10-19 | $1.12 | $252.7M | +28.7% | +27.3% | — | — |
| 2017-06-30Q2 FY2017 | 2017-07-20 | $0.97 | $224.3M | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-04-20 | $0.80 | $199.3M | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-02-17 | $0.96 | $207.5M | — | — | — | — |
| 2016-09-30Q3 FY2016 | 2016-10-20 | $0.87 | $198.6M | — | — | — | — |
Need TCBIO data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.
More on TEXAS CAPITAL BANCSHARES INC/TX
Compare with peers
- PTACW · Patriot Acquisition Corp.
- USMX · Corgi U.S. Mid-Cap 2x Daily ETF
- USSX · Corgi U.S. Small-Cap 2x Daily ETF
- VSMPX · Vanguard Morningstar Total Stock Market Index Fund Institutional Plus Shares
- VTSAX · Vanguard Total Stock Market Index Fund Admiral Shares
- VITSX · Vanguard Total Stock Market Index Fund Institutional Shares